Satu Mustjoki
Helsingin yliopisto
H-index: 62
Europe-Finland
Top articles of Satu Mustjoki
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib-interim results from the … | Leukemia | Hjalmar Flygt Stina Söderlund Johan Richter Susanne Saussele Perttu Koskenvesa | 2024/2/28 |
Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironment | Journal for Immunotherapy of Cancer | Rita Turpin Ruixian Liu Pauliina M Munne Aino Peura Jenna H Rannikko | 2024 |
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes | Clinical Cancer Research | Bimarzhan Assatova Robert Willim Christopher Trevisani Garrett Haskett Khyati Maulik Kariya | 2024/2/9 |
Single-cell characterisation of tissue homing CD4+ and CD8+ T cell clones in immune-mediated refractory arthritis | Dipabarna Bhattacharya Jason Theodoropoulos Katariina Nurmi Timo Juutilainen Kari K Eklund | 2023/5/23 | |
Tracing back primed resistance in cancer via sister cells | Nature Communications | Jun Dai Shuyu Zheng Matías M Falco Jie Bao Johanna Eriksson | 2024/2/7 |
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia | Journal of Clinical Investigation | Tobias Suske Helena Sorger Gabriele Manhart Frank Ruge Nicole Prutsch | 2024/4/15 |
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib | Leukemia | Katerina Machova Polakova Ali Albeer Vaclava Polivkova Monika Krutska Katerina Vlcanova | 2024/2 |
Integrated drug profiling and CRISPR screening identify BCR:: ABL1-independent vulnerabilities in chronic myeloid leukemia | Blood, The Journal of the American Society of Hematology | Olli Dufva Jan Koski Pilvi Maliniemi Aleksandr Ianevski Jay Klievink | 2020/2/27 |
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib–interim results from the DAstop2 trial | Leukemia | Hjalmar Flygt Stina Söderlund Johan Richter Susanne Saussele Perttu Koskenvesa | 2024/1/26 |
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission | Journal of Clinical Oncology | Francois-Xavier Mahon Markus Pfirrmann Stéphanie Dulucq Andreas Hochhaus Panayiotis Panayiotidis | 2024/3/12 |
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation | Leukemia | Jani Huuhtanen Shady Adnan-Awad Jason Theodoropoulos Sofia Forstén Rebecca Warfvinge | 2024/1 |
Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma | The Journal of Clinical Investigation | Jani Huuhtanen Henna Kasanen Katriina Peltola Tapio Lönnberg Virpi Glumoff | 2023/3/29 |
SBNO2 is a critical mediator of STAT3-driven hematological malignancies | Blood | Tania Brandstoetter Johannes Schmoellerl Reinhard Grausenburger Sebastian Kollmann Eszter Doma | 2023/4/13 |
S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL | HemaSphere | Markus Pfirrmann Francois-Xavier Mahon Stéphanie Dulucq Andreas Hochhaus Panayiotis Panayiotidis | 2023/8/1 |
Single cell multi-omics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response | bioRxiv | Rebecca Warfvinge Linda Geironson Ulfsson Parashar Dhapola Fatemeh Safi Mikael NE Sommarin | 2023/8/18 |
Clonal Trafficking of Individual T Cells between Peripheral Blood and Inflamed Synovial Tissue in Patients with Immune-Mediated Refractory Arthritis | Blood | Dipabarna Bhattacharya Jason Theodoropoulos Katariina Nurmi Timo Juutilainen Kari K Eklund | 2023/11/28 |
Single-Cell Transcriptomics Reveals Adaptive NK Cell and Antigen-Specific T Cell Responses Shaped by CMV Viremia Post-Hematopoietic Stem Cell Transplant | Blood | Aino-Elina Häkkinen Jani Huuhtanen Sofie Lundgren Riitta Niittyvuopio Harri Lähdesmäki | 2023/11/28 |
Small molecule STAT3/5 inhibitors exhibit therapeutic potential in acute myeloid leukemia and extra-nodal natural killer/T cell lymphoma | bioRxiv | Daniel Pölöske Helena Sorger Anna Schönbichler Elvin D de Araujo Heidi A Neubauer | 2023 |
Single-cell functional genomics of natural killer cell evasion by tumor cells | Cancer Research | Olli Dufva Sara Gandolfi Jani Huuhtanen Olga Dashevsky Khalid Saeed | 2023/4/4 |
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma | Dipabarna Bhattacharya Petrus Järvinen Sara Tornberg Harry Nísen Marco Donia | 2023 |
